These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 807447)

  • 1. Absence of differences in platelet dihydroxyphenylalanine (dopa) oxidase polymorphism in health and Duchenne's muscular dystrophy.
    Pacold I; Morgan J; Cohen L
    Clin Genet; 1975; 7(5):435-41. PubMed ID: 807447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet diphenoloxidases in progressive muscular dystrophy (P.M.D.).
    Dèmos J
    Clin Genet; 1973; 4(2):79-90. PubMed ID: 4199873
    [No Abstract]   [Full Text] [Related]  

  • 3. Diphenoloxidases in X-linked recessive (Duchenne) muscular dystrophy.
    Demos JJ; Tuil DG; Katz PC; Berthelon MA; Dautreaux B; Premont N
    Hum Genet; 1981; 59(2):154-60. PubMed ID: 6799386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enzymology and myopathy. Diagnostic and genetic value of determination of platelet diphenol-oxydase activity].
    Demos J; Berthelon M
    Arch Fr Pediatr; 1972 Oct; 29(8):793-9. PubMed ID: 4632798
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum cytoplasmic and mitochondrial aspartate aminotransferase in Duchenne's progressive muscular dystrophy.
    Janik P; Nowak I; Niebrój-Dobosz I
    Mater Med Pol; 1994; 26(3):101-4. PubMed ID: 7603078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leber's congenital amaurosis with Duchenne's muscular dystrophy.
    Hazariwala K; Brownstein S; Polomeno R; Little JM; Labuda D
    Can J Ophthalmol; 1990 Jun; 25(4):202-7. PubMed ID: 1972344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum enzyme lowering and other effects of diethylstilbestrol (DIES) in Duchenne's muscular dystrophy (DMD).
    Cohen L; Morgan J; Schulman S; Lawrence A
    J Lab Clin Med; 1971 Nov; 78(5):797-8. PubMed ID: 5128833
    [No Abstract]   [Full Text] [Related]  

  • 8. Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy.
    Arahata K; Ishihara T; Kamakura K; Tsukahara T; Ishiura S; Baba C; Matsumoto T; Nonaka I; Sugita H
    N Engl J Med; 1989 Jan; 320(3):138-42. PubMed ID: 2643040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A
    S Afr Med J; 1982 Nov; 62(21):765-7. PubMed ID: 7135141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
    Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
    N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable effects of corticosteroid treatment of serum enzyme activities in Duchenne's muscular dystrophy.
    Cohen L; Morgan J; Bozyk ME
    Res Commun Chem Pathol Pharmacol; 1977 Jul; 17(3):529-38. PubMed ID: 70832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of the test with the drug Nakom on the dynamics of excretion of catecholamines and DOPA in children with Duchenne's progressive muscular dystrophy].
    Badalian LO; Temin PA; Grinio ZN; Amanova ZN; Sadovskaia IuE
    Pediatriia; 1985 May; (5):54-5. PubMed ID: 3931050
    [No Abstract]   [Full Text] [Related]  

  • 13. [Description of a family with Duchenne's type of progressive muscular dystrophy with an unusually benign course].
    Domzal T; Kotowicz J
    Neurol Neurochir Pol; 1967; 1(5):593-8. PubMed ID: 6064457
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical polymorphism and genetic heterogeneity in Duchenne's progressive muscular dystrophy in girls (a review)].
    Zavadenko NN; Temin PA; Malygina NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(11):123-6. PubMed ID: 3066079
    [No Abstract]   [Full Text] [Related]  

  • 15. The X chromosome in Duchenne's muscular dystrophy.
    Katsantoni A
    Clin Genet; 1976 Mar; 9(3):371-3. PubMed ID: 1261076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of recombinant DNA studies for the identification of carriers of Duchenne's muscular dystrophy].
    Veenema H; Leschot NJ; van Ommen GJ; Pearson PL
    Ned Tijdschr Geneeskd; 1985 Jun; 129(24):1137-41. PubMed ID: 4022155
    [No Abstract]   [Full Text] [Related]  

  • 17. [Duchenne's muscular dystrophy in a girl with 45,X/46,XX chromosomal mosaicism].
    Aver'ianov IuN; Bogomazov EA; Logunova LV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(10):1449-52. PubMed ID: 930487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid composition of erythrocytes. Findings in Duchenne's muscular dystrophy and myotonic atrophy.
    McLaughlin J; Engel WK
    Arch Neurol; 1979 Jun; 36(6):351-4. PubMed ID: 454232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Individualization of carriers of Duchenne's muscular dystrophy . Problems and prospectives].
    Comi G; Comola M; Galardi G; Piattoni F; Erembourg L; Canal N
    Minerva Pediatr; 1986 Aug; 38(15-16):625-32. PubMed ID: 3796511
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of retabolyl on the dynamics of urinary catecholamine and DOPA excretion and electroneuromyographic indices in patients with Duchenne's myodystrophy].
    Badalian LO; Temin PA; Amanova ZN; Avakian GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(11):1630-5. PubMed ID: 6441403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.